Repository: UIHistories Project: Board of Trustees Minutes - 1986 [PAGE 416]

EXTRACTED TEXT FROM PAGE:

1985]

UNIVERSITY OF ILLINOIS

405

1. Laser Beam Detector — Robert J. Gordon, professor of chemistry, and Andrzej Z. Ringwelski, former research associate, Department of Chemistry, Chicago. University Patents, Inc. ( U P I ) , reported that it does not elect to subject this invention to the terms of its servicing agreement with the University. I t was determined that the invention did not fit the usual legal tests of patentability and that it would be difficult to obtain any reasonable patent protection on the invention. T h e University Patent Committee has reviewed these findings and recommends that the University release its rights in this invention to the inventors, subject to the retention of shop rights in the invention by the University. 2. Cloning of Two Alkaline Phosphatase Genes Positioned in Tandem in Bacillus Licheniformis MC 14—-Marion F . Hulett, associate professor, Department of Biological Sciences, Chicago. U P I reported that it does not elect to subject this invention to the terms of its servicing agreement with the University. It was determined that the invention, in its present stage of development, is not licensable. It was also determined that patent protection for the invention is not obtainable. The University Patent Committee has reviewed these findings and recommends that the University release its rights in this invention to the inventor, subject to the retention of shop rights in the invention by the University. I concur.

On motion of Mr. Howard, these recommendations were approved. By consensus, the board agreed that one roll call vote would be taken and considered the vote on each agenda item nos. 9 through 17 inclusive. The recommendations were individually discussed but acted upon at one time. (The record of board action appears at the end of each item.)

Loan to Kidney Stone Center of Chicago, Ltd. (Use of Lithotripter)

(9) In 1984, the Illinois Health Facilities Planning Board (IHFPB) directed that only three "lithotripters" would be allowed for Chicago area hospitals. The lithotripter, a new medical instrument which costs $1.5 million, uses sound waves to break up kidney stones and is considered highly innovative equipment. RushPresbyterian-St. Luke's Medical Center and Michael Reese Hospital and Medical Center have been authorized to purchase lithotripters; and the IHFPB stated that it would authorize a lithotripter to a joint program sponsored by the University of Chicago, the University of Illinois, and Northwestern University. Pursuant to this action, a decision was made to locate the lithotripter at Northwestern University's downtown campus. A "Kidney Stone Center of Chicago, Ltd." will be established at the University of Chicago. The center will be the focal point for access to the lithotripter at Northwestern and for providing clinical services for patients. Faculty from the three institutions will staff the center. The legal nature of the center has been evaluated. One concern has been the anti-trust considerations relating to access to the lithotripter and the uniformity of physician fees. The establishment of a professional corporation would minimize these concerns. Technically, the corporation would be owned by three persons, the heads of urology at Northwestern and Chicago, and the dean of the College of Medicine at the University of Illinois. In turn, the dean would designate the head of urology as his representative on the Board of Directors. Each of these individuals is required to relinquish his interest in the corporation should he cease to hold his respective office. T o fund the initial costs of establishing the center, each institution has been requested to advance up to $50,000 to the corporation, a loan which would be